MyChesCo on MSN3h
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal SyndromePleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback